Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió acceptadaData de publicació
Tots els drets reservats
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/222982
Epilepsy in glioblastoma patients: basic mechanisms and current problems in treatment
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Glioblastoma-related epilepsy requires paying careful attention to a combination of factors with an integrated approach. Major interrelated issues must be considered in the seizure care of glioblastoma patients. Seizure control frequently requires the administration of antiepileptic drugs simultaneously with other treatments, including surgery, radiotherapy and chemotherapy, with complete seizure relief often being difficult to achieve. The pharmacological interactions between antiepileptic drugs and antineoplastic agents can modify the activity of both treatments, compromising their efficacy and increasing the probability of developing adverse events related to both therapies. This review summarizes the new pathophysiological pathways involved in the epileptogenesis of glioblastoma-related seizures and the interactions between antiepileptic drugs and oncological treatment, paying special attention to its impact on survival and the current evidence of the antiepileptic treatment efficacy, including the potential usefulness of new third-generation compounds.
Matèries
Matèries (anglès)
Citació
Citació
BRUNA, Jordi, MIRÓ, Júlia, VELASCO, Roser. Epilepsy in glioblastoma patients: basic mechanisms and current problems in treatment. _Expert Review of Clinical Pharmacology_. 2013. Vol. 6, núm. 3, pàgs. 333-344. [consulta: 20 de gener de 2026]. ISSN: 1751-2433. [Disponible a: https://hdl.handle.net/2445/222982]